| ISSN |
2220-3206 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Psychiatry |
| Manuscript Type |
Minireviews |
| Article Title |
Review of clinical medication adherence in patients with schizophrenia
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Fei Zhao, Hua Zhong, Pei-Pei Kang, Shan-Mei Sun, Tian-Qi Zhang, Sai-Nan Cui and Shi-Jie Bi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Fei Zhao, Chief Physician, MD, Department of Gerontology, The First Affiliated Hospital of Shandong First Medical University, No. 16766 Jingshi Road, Lixia District, Jinan 270000, Shandong Province, China. qfsyyzf@163.com |
| Key Words |
Medication adherence; Schizophrenia; Long-acting injectable antipsychotics; Psychological interventions; Digital health technologies; Ethical-legal challenges |
| Core Tip |
Medication adherence is critical for managing symptoms, improving prognosis, and enhancing quality of life in patients with schizophrenia. This article examines the multifaceted factors influencing adherence, including symptom severity, attitudes toward medication, social support, and healthcare team communication. It evaluates assessment tools such as the Morisky Scale, electronic monitoring devices, and biomarkers, while highlighting effective strategies like long-acting injectable antipsychotics, psychological interventions, and multidisciplinary team efforts. Future directions emphasize innovative drug formulations, digital health technologies, and supportive policies. However, ethical, legal, and privacy challenges require further exploration. |
| Publish Date |
2025-11-27 09:20 |
| Citation |
Zhao F, Zhong H, Kang PP, Sun SM, Zhang TQ, Cui SN, Bi SJ. Review of clinical medication adherence in patients with schizophrenia. World J Psychiatry 2025; 15(12): 108191 |
| URL |
https://www.wjgnet.com/2220-3206/full/v15/i12/108191.htm |
| DOI |
https://dx.doi.org/10.5498/wjp.v15.i12.108191 |
